Anaemia of chronic renal failure is the onset of anaemia caused by an underlying chronic kidney disease. As patients’ kidney function decreases to around 20 to 50%, their risk of developing anaemia increases. This is due to the kidney’s inability to produce a sufficient amount of erythropoietin (EPO), the hormone that prompts the bone marrow to produce red blood cells. Anaemia of chronic renal failure can also be caused or aggravated by blood loss if the patient is undergoing haemodialysis. Symptoms include weakness, fatigue, body aches, syncope, chest discomfort, palpitations, cold intolerance, sleep disturbances, and loss of appetite, among others.
Anaemia of chronic renal failure is a serious medical condition that worsens over time. Thus, patients require continuous treatment and management that involves maintaining stable haemoglobin levels through advanced erythropoiesis stimulation. This can only be achieved under the supervision of doctors who specialise in renal disease.
Southeast Asians suffering from anaemia of chronic renal failure can seek specialist care within their own region. This is because renal care is one of the specialisations that Thailand is best known for. The country has a large number of diagnostic, renal care, and dialysis centres that focus on providing comprehensive and holistic care for all patients with kidney problems.
High-quality renal care is also widely available in Singapore, which has gained the reputation as the most reliable Southeast Asian medical tourism destination. As one of the pioneering Asian countries to offer medical services to foreign patients, Singapore’s medical facilities are tried and tested. Its healthcare system is recognised by the World Health Organisation (WHO) as the best in the region.
Meanwhile, Malaysia is fast emerging as a top-notch medical tourism destination. The country is a relatively new favourite among medical tourists. It offers world-class treatments and procedures at much more affordable cost. The government has also invested in facilities that develop new treatments. One example is Cell Malaysia, which develops stem cell treatments for chronic diseases.
The time it takes for patients to experience the benefits of erythropoietin treatment depends on individual factors, such as the severity of anaemia and the degree of kidney dysfunction. As such, patients should be prepared to stay in their medical tourism destination of choice for prolonged periods if the treatment so requires. This is why more and more patients are opting to go to Southeast Asia where healthcare costs are significantly lower.